Manitex Capital Inc. (TSXV: MNX)
Canada
· Delayed Price · Currency is CAD
0.0500
-0.0200 (-28.57%)
Dec 27, 2024, 9:44 AM EST
Manitex Capital Company Description
Manitex Capital Inc. focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies. It also holds a portfolio of marketable securities. Manitex Capital Inc. is headquartered in Kirkland, Canada.
Manitex Capital Inc.
Country | Canada |
Industry | Investors, not elsewhere classified |
Employees | 15 |
CEO | Steven Saviuk |
Contact Details
Address: 16667 Hymus Boulevard Kirkland, H9H 4R9 Canada |
Stock Details
Ticker Symbol | MNX |
Exchange | TSX Venture Exchange |
Fiscal Year | November - October |
Reporting Currency | CAD |
SIC Code | 6799 |
Key Executives
Name | Position |
---|---|
Steven Saviuk CA | Chairman, President and Chief Executive Officer |
Helen Saviuk CA | Chief Financial Officer and Director |
Ronald S. Perry CA, CPA | Secretary |
Kristof Biniecki Ph.D. | Vice President of Scientific Affairs - Valeo Pharma Inc |
Marc F. Leger | Executive Vice President of Commercial Operations - Valeo Pharma Inc |
Nathalie Therrien | Vice-President of QA and Regulatory Affairs - Valeo Pharma Inc. |
Luc Mainville M.B.A. | Senior Vice President and Chief Financial Officer of Valeo Pharma Inc |